Sidransky David is a director of Orgenesis Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Orgenesis Inc.
21 Dec 23
4
CHAMPIONS ONCOLOGY, INC.
7 Nov 23
4
CHAMPIONS ONCOLOGY, INC.
17 Aug 23
4
Old Ayala, Inc
23 Jan 23
4
Ayala Pharmaceuticals, Inc.
23 Jan 23
4
Orgenesis Inc.
29 Dec 22
4
CHAMPIONS ONCOLOGY, INC.
14 Oct 22
4
Ayala Pharmaceuticals, Inc.
15 Jun 22
5
Orgenesis Inc.
14 Feb 22
4
CHAMPIONS ONCOLOGY, INC.
9 Nov 21
Recent insider trades
| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 20 Dec 23 | ORGS Orgenesis | Stock Option Common Stock | Grant | Acquire A | No | No | 0.45 | 20,450 | 9.20 k | 20,450 |
| 3 Nov 23 | CSBR Champions Oncology | Option to purchase Common Stock Common Stock | Grant | Acquire A | No | No | 5.51 | 15,495 | 85.38 k | 15,495 |